# Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder

> **NCT06790823** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shiraz University of Medical Sciences** · enrollment: 40 (actual)

## Conditions studied

- Depressive Disorder
- Depressive Disorder, Major Depressive Disorder

## Interventions

- **DRUG:** The probiotic supplement (Moodamin capsuls)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06790823
- **Lead sponsor:** Shiraz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-15
- **Primary completion:** 2023-04-12
- **Final completion:** 2023-04-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06790823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06790823, "Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06790823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*